US Patent Issued to SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS on Aug. 11 for "Methods for treating chronic rhinosinusitis with nasal polyps by administering an antibody antagonist of IL-4R" (American, French Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,709, issued on Aug. 11, was assigned to SANOFI BIOTECHNOLOGY (Gentilly, France) and REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Methods for treating chronic rhinosinusitis with nasal polyps by administering an antibody antagonist of IL-4R" was invented by Leda Mannent (Paris), Gianluca Pirozzi (Bridgewater, N.J.), Brian Swanson (Bridgewater, N.J.), Allen Radin (New York), Namita A. Gandhi (New York), Robert Evans (New York) and Jennifer Hamilton (Hopewell Junction, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for decreasing a nasal polyp score in a subject. The methods include administering to a s...